about
α-Glucosidase inhibitor miglitol attenuates glucose fluctuation, heart rate variability and sympathetic activity in patients with type 2 diabetes and acute coronary syndrome: a multicenter randomized controlled (MACS) studyN-terminal pro-brain natriuretic peptide and associated factors in the general working population: a baseline survey of the Uranosaki cohort study.Increased amputation risk with canagliflozin treatment: behind the large cardiovascular benefit?Cardiovascular and renal protective role of angiotensin blockade in hypertension with advanced CKD: a subgroup analysis of ATTEMPT-CVD randomized trial.Intensive Treat-to-Target Statin Therapy in High-Risk Japanese Patients With Hypercholesterolemia and Diabetic Retinopathy: Report of a Randomized Study.Achieving LDL-C target levels less than 70 mg/dL may provide extra cardiovascular protection in high-risk patients: exploratory analysis of the Standard Versus Intensive Statin Therapy for Patients With Hypercholesterolemia and Diabetic Retinopathy SDevelopment of an immunodeficient pig model allowing long-term accommodation of artificial human vascular tubesCOA-Cl (2-Cl-C.OXT-A) can promote coronary collateral development following acute myocardial infarction in miceRandomized Evaluation of Anagliptin vs Sitagliptin On low-density lipoproteiN cholesterol in diabetes (REASON) Trial: A 52-week, open-label, randomized clinical trial.Author Correction: Randomized Evaluation of Anagliptin vs Sitagliptin On low-density lipoproteiN cholesterol in diabetes (REASON) Trial: A 52-week, open-label, randomized clinical trialEffect of Empagliflozin on Endothelial Function in Patients With Type 2 Diabetes and Cardiovascular Disease: Results from the Multicenter, Randomized, Placebo-Controlled, Double-Blind EMBLEM TrialTotal adiponectin is associated with incident cardiovascular and renal events in treated hypertensive patients: subanalysis of the ATTEMPT-CVD randomized trialPublisher Correction: Development of an immunodeficient pig model allowing long-term accommodation of artificial human vascular tubesFebuxostat does not delay progression of carotid atherosclerosis in patients with asymptomatic hyperuricemia: A randomized, controlled trial
P50
Q33883808-6D0FF9DD-542B-4B68-9BB5-999AD0044250Q33918896-55782590-9154-4837-A9AF-E7510411488FQ42376494-2BF64CEB-EC23-4396-BAC1-9884750900F7Q49912898-95B4E9F0-F0CF-40F2-AC24-39BFC76AB9C6Q52601707-AA58FEF5-EC79-4387-9D23-034AA8C528EAQ58612826-1893AAED-67DE-4B13-8FED-CD9CE4B99FE7Q64051906-D666AFA2-3954-4CF8-B8B0-A4A903E954C6Q64116140-4F2C0B47-5E82-4D1D-A686-E5B8A288F62FQ64998583-9AEBD708-BB6B-48CD-8AB5-8667D1FE83CEQ89811025-D5D16A7C-C501-4E7A-82D2-557C186F90BEQ90166982-B9649900-AE5C-40EF-A70C-71B284EDC62BQ91260359-0E5F91AD-7979-4363-BD06-77BD3D7C165FQ92460392-E18F34D1-10AE-4F0F-8EED-5829AB8B0A5FQ93150232-0DC7C17C-36C5-4598-A660-6F64DC645466
P50
description
researcher
@en
wetenschapper
@nl
name
Koichi Node
@en
Koichi Node
@nl
type
label
Koichi Node
@en
Koichi Node
@nl
prefLabel
Koichi Node
@en
Koichi Node
@nl
P31
P496
0000-0002-2534-0939